OR WAIT null SECS
December 23, 2021
Sanofi’s acquisition of Amunix will grant access to their promising immuno-oncology pipeline.
December 22, 2021
Tezpire (tezepelumab-ckko) has been approved as an add-on maintenance treatment for severe asthma.
December 20, 2021
The agency recommended granting conditional marketing authorization for use of Nuvaxovid in people 18 years of age and older.
December 17, 2021
Amgen and Syngene International have extended their research collaboration to 2026.
FDA has become embroiled in the debate over access to “chemical” or “medication” abortions through the prescribing and distribution of the abortifacient mifepristone.
Genezen has opened its new process development and analytical lab for viral vector production.
Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.
Lonza plans to ensure consistent product quality by incorporating Agilent’s analytics technology into its Cocoon platform.
December 16, 2021
Pfizer invested $68.5 million in a facility in Durham, NC.
FUJIFILM Irvine Scientific’s new manufacturing facility in Tilburg, the Netherlands, is now fully operational.